Evidence map›Paper›PMID 37215236›Full record

ReviewArchives of academic emergency medicine2023

Late Complications of COVID-19; An Umbrella Review on Current Systematic Reviews.

SeyedAhmad SeyedAlinaghi, AmirBehzad Bagheri, Armin Razi, Paniz Mojdeganlou, Hengameh Mojdeganlou, Amir Masoud Afsahi, Arian Afzalian, Parinaz Paranjkhoo, Ramin Shahidi, Pegah Mirzapour and 8 more

Abstract readReview
In one paragraph

Review in Archives of academic emergency medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Observational
  5. Article
  6. A Look at Archives of Academic Emergency Medicine Journal in 2023.Archives of academic emergency medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

SeyedAhmad SeyedAlinaghiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
AmirBehzad BagheriInterdisciplinary Consortium on Advanced Motion Performance, Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
Armin RaziSchool of medicine, Tehran University of Medical Sciences, Tehran, Iran.
Paniz MojdeganlouShahid Beheshti University of Medical Sciences, Tehran, Iran.
Hengameh MojdeganlouDepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Amir Masoud AfsahiDepartment of Radiology, School of Medicine, University of California, San Diego (UCSD), California, USA.
Arian AfzalianSchool of medicine, Tehran University of Medical Sciences, Tehran, Iran.
Parinaz ParanjkhooTurpanjian College of Health Sciences, American University of Armenia, Yerevan 0019, Armenia.
Ramin ShahidiSchool of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Pegah MirzapourIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Zahra PashaeiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Amin HabibiClinical Research Development Center, Qom University of Medical Sciences, Qom, Iran.
Parmida ShahbaziOrthopedic Department, Orthopedic Surgery Research Center (OSRC), Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Sahar Nooralioghli ParikhaniSchool of medicine, Tehran University of Medical Sciences, Tehran, Iran.
Narjes Sadat Farizani GohariSchool of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Yusuf PopoolaHealth Information Management Unit, Department of Computer Science, Adeleke University, Ede, Nigeria.
Esmaeil MehraeenDepartment of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran.
Daniel HackettPhysical Activity, Lifestyle, Ageing and Wellbeing Faculty Research Group, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Several clinical manifestations have been discovered for COVID-19 since the emergence of SARS-CoV-2, which can be classified into early, medium, and long-term complications. However, late complications can be present after recovery from acute COVID-19 illness. The present study aims to comprehensively review the available evidence of late complications related to COVID-19. Method: A search was conducted, using keywords, through electronic databases, which included Scopus, Web of Science, PubMed, and Embase up to August 29, 2022. Study selection was performed according to a strict inclusion and exclusion criteria. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) checklist was followed, and studies were appraised using the National Institute of Health (NIH) quality assessment and risk of bias tool. Results: In total, 50 studies were included, and nine distinct COVID-19 late complication categories were identified. A review of these studies revealed that neurologic and psychiatric (n=41), respiratory (n=27), musculoskeletal and rheumatologic (n=22), cardiovascular (n=9), and hepatic and gastrointestinal (n=6) complications were the most prevalent complications of long COVID-19. Conclusion: Almost all human body systems are affected by late complications of COVID-19 with different severity and prevalence. Fatigue and some other neuropsychiatric symptoms are the most common late complications among long COVID-19 patients. Respiratory symptoms including dyspnea (during exercise), cough, and chest tightness were the next most prevalent long-term complications of COVID-19. Since these complications are persistent and late, being aware of the signs and symptoms is essential for the healthcare providers and patients.

Indexed as

COVID-19Patient Outcome AssessmentPost-Acute COVID-19 SyndromeSARS-CoV-2

Identifiers

PMID37215236
PMCPMC10197916

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.